R. Landewé

The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal

Martín Rudwaleit, R. Landewé, Désirée van der Heijde et al. · Annals of the Rheumatic Diseases · 2009 · 943 citations

Medicine, Radiology, Diagnostic Radiology +10

European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update

Laure Gossec, Josef S Smolen, Sofía Ramiro et al. · Annals of the Rheumatic Diseases · 2016 · 913 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +16

Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial

Iain B. McInnes, Philip J. Mease, Bruce Kirkham et al. · The Lancet · 2015 · 850 citations

Life Sciences, Immunology, Pharmacotherapy +15

Secukinumab Inhibition of Interleukin-17A in Patients with Psoriatic Arthritis

Philip J. Mease, Iain B. McInnes, Bruce Kirkham et al. · New England Journal of Medicine · 2015 · 740 citations · Full text

Medicine, Immunology, Pharmacotherapy +17

ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis

Désirée van der Heijde, E. Lie, Tore K Kvien et al. · Annals of the Rheumatic Diseases · 2008 · 631 citations

Medicine, Clinical Sciences, Internal Medicine +12